Invention Grant
- Patent Title: Serine/threonine kinase inhibitors
-
Application No.: US17075380Application Date: 2020-10-20
-
Publication No.: US11376260B2Publication Date: 2022-07-05
- Inventor: Aleksandr Kolesnikov , Steven Do
- Applicant: GENENTECH, INC.
- Applicant Address: US CA South San Francisco
- Assignee: GENENTECH, INC.
- Current Assignee: GENENTECH, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Viksnins Harris Padys Malen LLP
- Main IPC: A61K31/53
- IPC: A61K31/53 ; A61P35/00 ; A61P35/02 ; A61P43/00 ; C07D471/16 ; A61K31/553 ; C07D498/16 ; A61K31/519 ; A61K31/5365 ; A61K31/542 ; A61K31/55 ; A61K45/06 ; C07D513/16
Abstract:
Compounds having the formula I wherein R1, X1, X2, X3 and X4 as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.
Public/Granted literature
- US20210106593A1 SERINE/THREONINE KINASE INHIBITORS Public/Granted day:2021-04-15
Information query
